HUP0203646A2 - Gyengített mikroorganizmusok alkalmazása fertőzések ellen - Google Patents

Gyengített mikroorganizmusok alkalmazása fertőzések ellen

Info

Publication number
HUP0203646A2
HUP0203646A2 HU0203646A HUP0203646A HUP0203646A2 HU P0203646 A2 HUP0203646 A2 HU P0203646A2 HU 0203646 A HU0203646 A HU 0203646A HU P0203646 A HUP0203646 A HU P0203646A HU P0203646 A2 HUP0203646 A2 HU P0203646A2
Authority
HU
Hungary
Prior art keywords
microorganism
infection
damages
subject
treatment
Prior art date
Application number
HU0203646A
Other languages
English (en)
Inventor
Francis Richard Brennan
Gordon Dougan
David William Holden
Joseph David Santangelo
Jacqueline Elizabeth Shea
Original Assignee
Microscience Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9930456.0A external-priority patent/GB9930456D0/en
Priority claimed from GBGB9930461.0A external-priority patent/GB9930461D0/en
Priority claimed from GBGB9930458.6A external-priority patent/GB9930458D0/en
Priority claimed from GBGB9930460.2A external-priority patent/GB9930460D0/en
Priority claimed from GBGB9930455.2A external-priority patent/GB9930455D0/en
Priority claimed from GBGB9930459.4A external-priority patent/GB9930459D0/en
Priority claimed from GBGB9930457.8A external-priority patent/GB9930457D0/en
Application filed by Microscience Limited filed Critical Microscience Limited
Publication of HUP0203646A2 publication Critical patent/HUP0203646A2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/42—Salmonella
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A találmány tárgyát gyengített mikroorganizmusok képezik, amelyekvakcinakészítményekben alkalmazhatók baktériumok vagy vírusok általokozott fertőzések megelőzésére vagy megszűntetésére. A gyengítőmutáción átment Salmonella mikroorganizmus károsítja egy, az Spi2patogenicitási szigeten elhelyezkedő gén kifejeződését és egy továbbimutáció folytán károsítja a c1pP, sifA, sseC vagy az ssaB génkifejeződését. A találmány tárgyát képezi a mikroorganizmus terápiásalkalmazása szisztémás bakteriális fertőzés ellen hatógyógyszerkészítmény előállítására pl. tífuszfertőzés ellen, valamintegy vakcinakészítmény, amely a mikroorganizmust, egy adjuvánst és egyfiziológiai szempontból elfogadható hígítót tartalmaz. Ó
HU0203646A 1999-12-23 2000-12-22 Gyengített mikroorganizmusok alkalmazása fertőzések ellen HUP0203646A2 (hu)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GBGB9930456.0A GB9930456D0 (en) 1999-12-23 1999-12-23 Vaccine compositions
GBGB9930461.0A GB9930461D0 (en) 1999-12-23 1999-12-23 Vaccine compositions
GBGB9930458.6A GB9930458D0 (en) 1999-12-23 1999-12-23 Vaccine compositions
GBGB9930460.2A GB9930460D0 (en) 1999-12-23 1999-12-23 Vaccine compositions
GBGB9930455.2A GB9930455D0 (en) 1999-12-23 1999-12-23 Vaccine compositions
GBGB9930459.4A GB9930459D0 (en) 1999-12-23 1999-12-23 Vaccine compositions
GBGB9930457.8A GB9930457D0 (en) 1999-12-23 1999-12-23 Vaccine compositions
PCT/GB2000/005002 WO2001047962A2 (en) 1999-12-23 2000-12-22 Attenuated microorganisms for the treatment of infection

Publications (1)

Publication Number Publication Date
HUP0203646A2 true HUP0203646A2 (hu) 2003-03-28

Family

ID=27562965

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203646A HUP0203646A2 (hu) 1999-12-23 2000-12-22 Gyengített mikroorganizmusok alkalmazása fertőzések ellen

Country Status (17)

Country Link
US (1) US20030059442A1 (hu)
EP (1) EP1240192A2 (hu)
JP (1) JP2003518933A (hu)
KR (1) KR20020079755A (hu)
CN (1) CN1411468A (hu)
AP (1) AP2002002549A0 (hu)
AU (1) AU2210001A (hu)
BR (1) BR0016616A (hu)
CA (1) CA2395382A1 (hu)
CZ (1) CZ20022444A3 (hu)
EA (1) EA200200704A1 (hu)
HK (1) HK1046913A1 (hu)
HU (1) HUP0203646A2 (hu)
NO (1) NO20022949D0 (hu)
NZ (1) NZ519477A (hu)
OA (1) OA12130A (hu)
WO (1) WO2001047962A2 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1640013A3 (en) * 2000-03-17 2007-02-21 Pharmacia & Upjohn Company LLC Inactivated Salmonella vaccines
ATE300949T1 (de) 2000-03-17 2005-08-15 Pharmacia & Upjohn Co Llc Ssa inaktivierte salmonella impfstoffe
AU2001292035A1 (en) * 2000-09-29 2002-04-08 Microscience Limited Attenuated salmonella microorganisms comprising a mutation in the sifa gene
CA2678698A1 (en) * 2007-02-23 2008-10-02 The Penn State Research Foundation Use of an avirulent bordetella mutant as a live vaccine vector
CA2958892C (en) * 2014-08-29 2023-01-24 The Regents Of The University Of California Vaccine for livestock production systems
KR102424707B1 (ko) * 2020-10-12 2022-07-25 전북대학교산학협력단 표적단백질발현을 증가시킨 진핵세포질 내 다중항원발현용 재조합벡터 및 진핵세포 내 벡터전달시스템용 살모넬라 티피뮤리움의 조합 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8912330D0 (en) * 1989-05-30 1989-07-12 Wellcome Found Live vaccines

Also Published As

Publication number Publication date
OA12130A (en) 2006-05-05
AU2210001A (en) 2001-07-09
JP2003518933A (ja) 2003-06-17
NO20022949L (no) 2002-06-19
HK1046913A1 (zh) 2003-01-30
AP2002002549A0 (en) 2002-06-30
CZ20022444A3 (cs) 2002-10-16
WO2001047962A2 (en) 2001-07-05
US20030059442A1 (en) 2003-03-27
BR0016616A (pt) 2002-10-29
NO20022949D0 (no) 2002-06-19
EA200200704A1 (ru) 2003-08-28
CA2395382A1 (en) 2001-07-05
WO2001047962A3 (en) 2002-05-10
KR20020079755A (ko) 2002-10-19
WO2001047962A8 (en) 2002-10-31
CN1411468A (zh) 2003-04-16
EP1240192A2 (en) 2002-09-18
NZ519477A (en) 2004-04-30

Similar Documents

Publication Publication Date Title
HUP0202051A2 (hu) Tejsavbaktérium-kombináció és használata fertőzések és gyulladásos folyamatok megelőzésében és/vagy kezelésében
Crombach et al. Control of an epidemic spread of a multi-resistant strain of Acinetobacter calcoaceticus in a hospital
HUP0200206A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
AU1794601A (en) Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs
Weinstein The chemoprophylaxis of infection
ES2112818T1 (es) Composicion farmaceutica que comprende lactobacillus plantarum y arginina.
BR0006291A (pt) Bactéria do gênero salmonella, vacina para aproteção de animais contra a salmonelose, uso deuma bactéria, e, processo para a preparação deuma vacina
NO953192D0 (no) Farmasöytiske preparater av cefaclor
HUP0203646A2 (hu) Gyengített mikroorganizmusok alkalmazása fertőzések ellen
Lobel Short term therapy for uncomplicated urinary tract infection today. Clinical outcome upholds the theories
WO2022011271A3 (en) Probiotics for use in the prevention or treatment of illness and/or symptoms associated with coronaviruses
HUP0400840A2 (hu) Kis molekulatömegű hialuronsav immunogén készítményei, és eljárások A. csoportbeli és C. csoportbeli Streptococcusok által okozott fertőzések és betegségek megelőzéséhez, kezeléséhez és diagnózisához
DK0625190T3 (da) Bakterie, der forårsager fjerkræsygdom, og deraf afledt vaccine
HUP0303878A2 (hu) Himlő elleni vakcina
Shakir et al. Effect on experimental palatal candidosis in the Wistar rat of removal and re-insertion of acrylic appliances
WO2023281415A3 (en) Bacteria strains for topical skin care
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
HUP0200162A2 (hu) Haemophilus somnus transzferrin-kötő fehérjék klónozása és expresszálása
BR0007966A (pt) Composições e métodos para o tratamento e a prevenção de infecção bacteriana patogênica com base na função essencial da metilação do dna na virulência bacteriana
Garrod Chemoprophylaxis.
Suhashini et al. Acacia catechu a Pivotal in Root Canal Treatment-A Review
Mosaico et al. Resolution of an Atypical Gingival Swelling Unrelated to Plaque and Tartar Treated with Probiotics of the Lactobacillus reuteri Group: A Long-term Success
HUP0302371A2 (hu) Béta-blokkolót és adott esetben koleszterinszint-csökkentőt tartalmazó új gyógyszerkészítmény
WO2023240160A3 (en) Pharmaceutical compositions and uses thereof
WO2023062163A3 (fr) Bacteries utiles dans la prevention et/ou le traitement de pathologies respiratoires